Selected Grants
Untangling the diversity in the genetic architecture of late-onset Alzheimer's disease using single cell multi-omics
ResearchCo Investigator · Awarded by National Institutes of Health · 2022 - 2025Design and production of adeno-associated vectors (AAV) for Kallyope
ResearchPrincipal Investigator · Awarded by Kallyope, Inc · 2023 - 2025Gene Therapy of ATP1A3 Related Disease
ResearchInvestigator · Awarded by North Carolina Biotechnology Center · 2023 - 2025A novel gene-therapy strategy for Parkinson's disease (PD): Epigenome editing mediated-regulation of SNCA expression
ResearchCo-Principal Investigator · Awarded by Michael J. Fox Foundation for Parkinson's Research · 2022 - 2024Seelos SRA-PD Model Vectors Generation for CRO SLS004
ResearchPrincipal Investigator · Awarded by Seelos Therapeutics · 2022 - 2024APOE-targeted therapy for precision medicine in late onset Alzheimer's disease: A novel epigenome editing approach for downregulation of APOEe4 expression
ResearchPrincipal Investigator · Awarded by CLAIRIgene · 2022 - 2023Seelos SRA 009- Amplification and preparation of Adeno-associated vectors (AAVs) for production
ResearchPrincipal Investigator · Awarded by Seelos Therapeutics · 2022 - 2023Production of Adeno-Associated Vectors (AAVs) for Kallyope
ResearchPrincipal Investigator · Awarded by Kallyope, Inc · 2019 - 2023Production of lentiviral vectors (LVs)
ResearchPrincipal Investigator · Awarded by Falcon Therapeutics · 2018 - 2019Production of Adeno-Associated Vectors (AAVs)
ResearchPrincipal Investigator · Awarded by Kallyope, Inc · 2018 - 2018External Relationships
- CLAIRIgene
- Seelos Therapeutics
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.